Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.

about

Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life.

P2860

Q47244918-002410E5-CBAC-432E-A9C1-81AABFECA210

P2860

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.

Item

http://www.wikidata.org/entity/Q42370565

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Onabotulinum toxin A in the tr ...... on and special considerations.

@en

Onabotulinum toxin A in the tr ...... on and special considerations.

@nl

type

Item

label

Onabotulinum toxin A in the tr ...... on and special considerations.

@en

Onabotulinum toxin A in the tr ...... on and special considerations.

@nl

prefLabel

Onabotulinum toxin A in the tr ...... on and special considerations.

@en

Onabotulinum toxin A in the tr ...... on and special considerations.

@nl

P1476

Onabotulinum toxin A in the tr ...... on and special considerations.

@en

P2093

Piero Barbanti

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials

Development of onabotulinumtoxinA for chronic migraine

Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

The International Classification of Headache Disorders, 3rd edition (beta version)

The International Classification of Headache Disorders: 2nd edition

Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

Abnormal brain processing of cutaneous pain in patients with chronic migraine.

Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year.

Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.

P304

2319-2329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JPR.S113614

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrizia Ferroni

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29033605

http://www.w3.org/2001/XMLSchema#string

P932

5628659

http://www.w3.org/2001/XMLSchema#string

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.

about

P2860

P2860

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932